![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
North China Pharmaceutical Group Aino Co., Ltd. Shijiazhuang Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Ivermectin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2004-070 - Rev 01
This Chemical Type CEP, issued on August 02, 2011, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1336 associated with this CEP further emphasizes